BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Ebola outbreak
Hantavirus
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Thursday, June 4, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
April 21, 2022
View Archived Issues
JY-201 ADC shows promise for tumors with low HER2 expression
Read More
Tarus Therapeutics targets adenosine A2A/A2B receptors with compounds TT-10 and TT-4
Read More
ABL-103 demonstrates potent in vitro and vivo antitumor activity
Read More
ASN-90, a novel OGA inhibitor with activity in models of tauopathies and alpha-synucleinopathies
Read More
CSPC Zhongqi Pharmaceutical Technology patents new ATM inhibitors
Read More
Chinese investigators disclose new compounds for COPD
Read More
Charles University in Prague synthesizes new TET1 inhibitors
Read More
Wigen Biomedicine Technology presents new GTPase KRAS inhibitors
Read More
Medshine Discovery synthesizes PRMT5 inhibitors
Read More
U.S. DoD supports Aclipse's development of M-102 for ALS
Read More
TATX-03 antibody cocktail shows in vitro neutralizing activity toward SARS-CoV-2 Omicron BA.2
Read More
Silo Pharma produces SPU-21 liposomes for preclinical study for rheumatoid arthritis
Read More
Dual adenosine receptor A2A/A2B antagonist M-1069 reduces tumor growth in vivo
Read More
KLS-13019 prevents the development of chemotherapy-induced peripheral neuropathy in rodents
Read More
Astrocyte-produced enzyme affects neuronal activity, stroke outcomes
Read More
